| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |